Evidence map›Paper›PMID 33846689›Full record

ArticleNew microbes and new infections2021

First detection of SARS-CoV-2 variant B.1.1.7 in Senegal.

A Padane, A Kanteh, N Leye, A Mboup, J Manneh, M Mbow, P A Diaw, B P Ndiaye, G Lo, C I Lo and 11 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in New microbes and new infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Rapidly rising cases with Omicron in Senegal.New microbes and new infections · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

A PadaneInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
A KantehMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, London, UK.
N LeyeInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
A MboupInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
J MannehMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, London, UK.
M MbowInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
P A DiawInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
B P NdiayeInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
G LoInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
C I LoIHU Méditerranée Infection, Marseille, France.
A AhoudiInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
A Gueye-GayeInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
J J N MalomarDistrict Sanitaire de Mbour, Thiès, Senegal.
A DiaInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
Y A DiaInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
N D DiagneInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
D WadeInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
A K SesayMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, London, UK.
N C Toure-KaneInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.
U DalessandroMedical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, London, UK.
S MboupInstitut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Africabritish variantCOVID-19genome sequencingSARS-CoV-2SenegalUK variant

Identifiers

PMID33846689
PMCPMC8026401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.